Mosaic Therapeutics, Ltd ('Mosaic') a targeted oncology therapeutics company dedicated to resolving cancer's complexity with new combination therapies for patients, today announces the in-licensing of ...

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...

Summit and Akeso report Phase 3 success as ivonescimab shows PFS gains in NSCLC trial, with new studies and collaborations ...

Cycuria aims to revolutionise treatment of hard-to-treat blood cancers with a first-in-class protein-based therapeutic approach specifically targeting both tumour cells and tumour stem cellsAdvisory ...

Storgard, M.D., as Chief Medical Officer (CMO ... Ph.D., chairperson and chief executive officer of Design Therapeutics. “His extensive expertise in clinical development and regulatory strategy ...

Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have described a new mechanism ...

Protara Therapeutics (TARA) announced the appointment of Leonardo Viana Nicacio as chief medical officer. Nicacio brings to Protara nearly 20 years of broad oncology, drug development, regulatory ...

therapeutics, today announced that Dr. Eyal Attar has joined the company as Chief Medical Officer (CMO). Dr. Attar brings to Halda over 25 years of biotechnology R&D and clinical trial experience ...